GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Science, American Association for the Advancement of Science (AAAS), Vol. 375, No. 6582 ( 2022-02-18)
    Abstract: Endocrine disrupting chemicals (EDCs) are compounds that interfere with physiological hormonal regulation. Humans are pervasively exposed to many different EDCs, and a growing body of evidence indicates that early life exposure to such EDC mixtures can induce changes in the human organism that underlie increased susceptibility to diseases throughout the life span, including neurodevelopmental disorders. Chemical regulation is, however, entirely based on the risk assessment of individual compounds, leaving the real-life impact of chemical mixtures unexamined and unregulated. This is relevant insofar as cumulative exposure to multiple compounds may be associated with adverse health outcomes even when the concentrations of individual chemicals fall below the regulatory dose. RATIONALE We set out to make the epidemiological associations between exposure to mixtures and health outcomes experimentally tractable, defining molecular pathways and dose responses that could be translated back to actual human exposures and thereby refine current risk assessment practices. As opposed to previous studies that focused on single compounds, we identified and tested an EDC mixture associated with adverse neurodevelopmental outcomes in the Swedish Environmental Longitudinal, Mother and child, Asthma and allergy (SELMA) pregnancy cohort (MIX N) by integrating epidemiological data with experimental toxicology and characterized real life–relevant exposure. RESULTS We used weighted quantile sum (WQS) regression to identify chemicals associated with language delay in children and included those chemicals in MIX N. MIX N was synthesized following the relative proportions and total concentrations found in the SELMA cohort. It was then tested in both in vitro and in vivo models. In human fetal primary neural stem cells and three-dimensional cortical brain organoids differentiated from human pluripotent stem cells, transcriptomic analysis showed that MIX N interferes with hormonal pathways and dysregulates expression of genes and biological pathways that are causally linked to autism spectrum disorders. Data from experiments in Xenopus leavis and Danio rerio , in vivo models validated by the Organisation for Economic Co-operation and Development (OECD), confirmed thyroid function as one of the key and unifying points of vulnerability to MIX N and linked thyroid disruption to neurodevelopmental effects measured as alterations in locomotor activity. The resulting dose-response relationships were then used to estimate a point of departure (POD), which is the toxicological measure to estimate no-effect concentration. This enabled us to apply a similar mixture approach (SMACH) where we (i) identified individuals in the SELMA study who were sufficiently similarly exposed compared with the experimental mixtures and (ii) determined the proportion of the SELMA children with exposure ranges of concern using the POD as reference. CONCLUSION Integrating experimental and epidemiological evidence, we established mechanistic and correlative evidence for neurodevelopmental adversities of an EDC mixture associated with language delay. Using the generated experimental data in a risk assessment concept, we found increased odds of language delay in offspring of up to 54% of pregnant women. These results emphasize the need to take mixtures into account during chemical testing and risk assessment and provide an integrative framework to guide risk assessment strategies. Diagram showing the integrative framework of the study. A mixture of EDCs was associated with adverse neurodevelopmental outcomes in the SELMA pregnancy cohort and was tested in human in vitro and in in vivo models to elucidate the molecular and functional impact of exposure. Experimental data were finally referred back to the cohort for risk assessment by a similar mixture approach. PFAS, perfluoroalkyl substance.
    Type of Medium: Online Resource
    ISSN: 0036-8075 , 1095-9203
    RVK:
    RVK:
    Language: English
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date: 2022
    detail.hit.zdb_id: 128410-1
    detail.hit.zdb_id: 2066996-3
    detail.hit.zdb_id: 2060783-0
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Translational Psychiatry, Springer Science and Business Media LLC, Vol. 12, No. 1 ( 2022-12-20)
    Abstract: Brain organoids are becoming increasingly relevant to dissect the molecular mechanisms underlying psychiatric and neurological conditions. The in vitro recapitulation of key features of human brain development affords the unique opportunity of investigating the developmental antecedents of neuropsychiatric conditions in the context of the actual patients’ genetic backgrounds. Specifically, multiple strategies of brain organoid (BO) differentiation have enabled the investigation of human cerebral corticogenesis in vitro with increasing accuracy. However, the field lacks a systematic investigation of how closely the gene co-expression patterns seen in cultured BO from different protocols match those observed in fetal cortex, a paramount information for ensuring the sensitivity and accuracy of modeling disease trajectories. Here we benchmark BO against fetal corticogenesis by integrating transcriptomes from in-house differentiated cortical BO (CBO), other BO systems, human fetal brain samples processed in-house, and prenatal cortices from the BrainSpan Atlas. We identified co-expression patterns and prioritized hubs of human corticogenesis and CBO differentiation, highlighting both well-preserved and discordant trends across BO protocols. We evaluated the relevance of identified gene modules for neurodevelopmental disorders and psychiatric conditions finding significant enrichment of disease risk genes especially in modules related to neuronal maturation and synapsis development. The longitudinal transcriptomic analysis of CBO revealed a two-step differentiation composed of a fast-evolving phase, corresponding to the appearance of the main cell populations of the cortex, followed by a slow-evolving one characterized by milder transcriptional changes. Finally, we observed heterochronicity of differentiation across BO models compared to fetal cortex. Our approach provides a framework to directly compare the extent of in vivo/in vitro alignment of neurodevelopmentally relevant processes and their attending temporalities, structured as a resource to query for modeling human corticogenesis and the neuropsychiatric outcomes of its alterations.
    Type of Medium: Online Resource
    ISSN: 2158-3188
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2022
    detail.hit.zdb_id: 2609311-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...